NORTHEAST REGIONAL CANCER INSTITUTE

What Northeast Regional Cancer Institute does

The organization over time

Each line starts at 100 in 2017, so what you read is the shape rather than the size: 150 means half as much again as 2017, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.

Balance sheet

Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2018 to 2019, from $3.5M to $4.0M (+13%).

How it's funded, over time

Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.

Government-grant reliance: 2017 11% · 2018 16% · 2019 17% · 2020 35% · 2021 25% · 2022 26% · 2023 32% · 2024 38% · 2025 39%. Grants only. Government contracts and fees sit inside program revenue.

Surplus & reserves

Operating surplus or deficit each year, and months of liquidity in hand. 7 of the last 9 reported years ran a deficit.

Leadership and staff

The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.

Who funds it, year by year

2017 → 2023: the base broadened from 4 funders to 6 funders, grant income fell $102k → $100k.

1 of 17 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 1% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.

Left out of every figure on this page: $93k from 2 payers (the payer shares this organization's board, largest Scranton Area Foundation Inc). These are real filings, and they are not money NORTHEAST REGIONAL CANCER INSTITUTE raised.

From the IRS filings of NORTHEAST REGIONAL CANCER INSTITUTE’s funders (the co-funder graph). Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

How concentrated its funding is

NORTHEAST REGIONAL CANCER INSTITUTE leans on a few funders — its largest provides 52% of grant income and the top three 77%; half comes from just 1 funder.

Largest funder’s share by year: 2017 98% · 2018 92% · 2019 57% · 2020 85% · 2021 98% · 2022 45% · 2023 50% — diversifying over time.

“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

How long its funders stay

25% of NORTHEAST REGIONAL CANCER INSTITUTE's funders are still giving 3 years after their first grant; 53% give in more than one year at all.

Share of funders still giving k years after their first recorded grant, pooled across every acquisition cohort. A funder counts as retained in a year only if it made a grant that year. Measured to FY2023, the last fiscal year that has finished arriving — a funder cannot be counted as lapsed in a year most filers have not reached.

Where its funders are

92% of NORTHEAST REGIONAL CANCER INSTITUTE's grant income comes from Pennsylvania funders.

Funder states come from each funder’s own filing. $7k arriving through sponsors registered in 1 state is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.